RSWM
Robertson Stephens Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $392K | Buy |
4,721
+1,261
| +36% | +$105K | 0.01% | 410 |
|
|
2025
Q1 | $281K | Sell |
3,460
-181
| -5% | -$14.7K | 0.01% | 458 |
|
|
2024
Q4 | $328K | Sell |
3,641
-20
| -0.5% | -$1.8K | 0.01% | 444 |
|
|
2024
Q3 | $362K | Sell |
3,661
-309
| -8% | -$30.5K | 0.01% | 491 |
|
|
2024
Q2 | $368K | Sell |
3,970
-522
| -12% | -$48.4K | 0.02% | 376 |
|
|
2024
Q1 | $426K | Buy |
4,492
+244
| +6% | +$23.2K | 0.02% | 366 |
|
|
2023
Q4 | $379K | Buy |
4,248
+23
| +0.5% | +$2.05K | 0.02% | 346 |
|
|
2023
Q3 | $309K | Sell |
4,225
-1,465
| -26% | -$107K | 0.02% | 369 |
|
|
2023
Q2 | $473K | Sell |
5,690
-6,015
| -51% | -$500K | 0.03% | 285 |
|
|
2023
Q1 | $892K | Sell |
11,705
-1,700
| -13% | -$130K | 0.07% | 210 |
|
|
2022
Q4 | $1.11M | Buy |
13,405
+9,570
| +250% | +$794K | 0.11% | 164 |
|
|
2022
Q3 | $304K | Buy |
+3,835
| New | +$304K | 0.03% | 277 |
|
|
2022
Q1 | – | Sell |
-2,000
| Closed | -$223K | – | 412 |
|
|
2021
Q4 | $223K | Hold |
2,000
| – | – | 0.02% | 367 |
|
|
2021
Q3 | $251K | Hold |
2,000
| – | – | 0.03% | 271 |
|
|
2021
Q2 | $270K | Hold |
2,000
| – | – | 0.03% | 278 |
|
|
2021
Q1 | $271K | Hold |
2,000
| – | – | 0.04% | 246 |
|
|
2020
Q4 | $281K | Hold |
2,000
| – | – | 0.06% | 199 |
|
|
2020
Q3 | $222K | Hold |
2,000
| – | – | 0.05% | 216 |
|
|
2020
Q2 | $223K | Buy |
+2,000
| New | +$223K | 0.06% | 171 |
|